Bruker Corp BRKR shares are trading lower by 6.6% to $67.80 during Thursday’s session after the company announced a public offering of 6 million shares of its common stock.
The offering comes with an option for underwriters to purchase an additional 900,000 shares within 30 days. The offering is set to close around May 31, pending customary conditions. The proceeds will be used to reduce debt from recent strategic acquisitions, including repaying part of its revolving credit agreement.
BofA Securities and J.P. Morgan are managing the offering, and the shares will be available on the Nasdaq Global Select Market and other venues at prevailing or negotiated prices.
See Also: US Q1 Economic Growth Downwardly Revised To 1.3%: Consumer Spending Falters
Should I Sell My BRKR Stock?
When deciding to hold on to or sell a stock, investors should consider their time horizon, unrealized gains and total return.
Shares of Bruker have decreased by 5.73% in the past year. An investor who bought shares of Bruker at the beginning of the year would take a loss of $5.42 per share if they sold it today. The stock has fallen 15.38% over the past month, meaning an investor who bought shares on Apr. 1 would see a capital loss of $24.03.
Bruker shares have an all-time high of $94.27, representing 40.96% upside from current levels.
Investors may also consider market dynamics. The Relative Strength Index can be used to indicate whether a stock is overbought or oversold. Bruker stock currently has an RSI of 26.13, indicating oversold conditions.
For access to advanced charting and analysis tools and stock data, check out Benzinga PRO. Try it for free.
BRKR has a 52-week high of $94.86 and a 52-week low of $53.79.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.